ReAlta Life Sciences
$66.9M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
ReAlta Life Sciences is currently valued at $190.0M as of May 20, 2025. The company has raised a total of $115.4M in funding.
Capital Efficiency
With a capital efficiency ratio of 1.65x, ReAlta Life Sciences has achieved a valuation that is 1.65 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
ReAlta Life Sciences's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is ReAlta Life Sciences Worth in 2025?
As of 2025, ReAlta Life Sciences is valued at $190.0M, based on the company's Later Stage VC funding round in May 20, 2025. This valuation positions ReAlta Life Sciences as one of the leading private companies in the sector.
ReAlta Life Sciences Valuation History
ReAlta Life Sciences's funding history demonstrates steady growth and investor confidence.
How ReAlta Life Sciences Valuation is Determined
Private company valuations like ReAlta Life Sciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
ReAlta Life Sciences Valuation FAQs
Is ReAlta Life Sciences profitable?
ReAlta Life Sciences has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does ReAlta Life Sciences's valuation compare to competitors?
ReAlta Life Sciences is valued at $190.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will ReAlta Life Sciences IPO?
ReAlta Life Sciences has not announced plans for an initial public offering. Until an IPO, investors can access ReAlta Life Sciences shares through secondary market platforms.